Dalbavancin>98%CAS 171500-79-1Антитела и рекомбинантные белки
Химическая структура
Биологическая активность
Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regimen.